BIOCRYST PHARMACEUTICALS, INC. 37,931,035 Shares of Common Stock (par value $0.01 per share) Underwriting AgreementBiocryst Pharmaceuticals Inc • November 18th, 2019 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 18th, 2019 Industry JurisdictionBioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 37,931,035 shares (the “Underwritten Shares”) of common stock, par value $0.01 per share, of the Company (“Common Stock”) and, at the option of the Underwriters, up to an additional 5,689,655 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”